Top

Published in:

01-12-2011 | Case Report

Pandemic H1N1 influenza A viral infection complicated by atypical hemolytic uremic syndrome and diffuse alveolar hemorrhage

Authors: Harin Rhee, Sang Heon Song, Yong Jae Lee, Hyun Ju Choi, Jin Hee Ahn, Eun Young Seong, Soo Bong Lee, Ihm Soo Kwak

Published in: Clinical and Experimental Nephrology | Issue 6/2011

Abstract

We report here on a case of a 27-year-old man with atypical hemolytic uremic syndrome and diffuse alveolar hemorrhage associated with influenza A H1N1 infection. Treatment with oseltamivir, plasma exchange and hemodiafiltration for the hemolytic uremic syndrome and meticulous supportive care with steroid pulse therapy for the pulmonary alveolar hemorrhage was successful in this case. We discuss the relationship between hemolytic uremic syndrome and influenza A and the underlying immunologic factors that should be tested in a patient with atypical hemolytic uremic syndrome. We also discuss using steroid therapy for patients with H1N1-related diffuse alveolar hemorrhage.

Tostivint I, Mougenot B, Flahault A, Vigneau C, Costa MA, Haymann JP, et al. Adult haemolytic and uraemic syndrome causes and prognostic factors in the last decade. Nephrol Dial Transplant. 2002;17:1228–34.PubMedCrossRef

Trachtman H, Sethna C, Epstein R, D’Souza M, Rubin L, Ginocchio C. Atypical hemolytic uremic syndrome associated with H1N1 influenza A virus infection. Pediatr Nephrol. 2011;26:145–6.PubMedCrossRef

Printza N, Roilides E, Kotsiou M, Zafeiriou D, Hatzidimitriou V, Papachristou F. Pandemic influenza A (H1N1) 2009-associated hemolytic uremic syndrome. Pediatr Nephrol. 2011;26:143–4.PubMedCrossRef

Golubovic E, Miljkovic P, Zivic S, Jovancic D, Kostic G. Hemolytic uremic syndrome associated with novel influenza A H1N1 infection. Pediatr Nephrol. 2011;26:149–50.PubMedCrossRef

Caltik A, Akyuz SG, Erdogan O, Demircin G. Hemolytic uremic syndrome triggered with a new pandemic virus: influenza A (H1N1). Pediatr Nephrol. 2011;26:147–8.PubMedCrossRef

Bento D, Mapril J, Rocha C. Triggering of atypical hemolytic uremic syndrome by influenza A (H1N1). Ren Fail. 2010;32:753–6.PubMedCrossRef

Al-Akash SI, Almond PS, Savell VH Jr, Gharaybeh SI, Hogue C. Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation. Pediatr Nephrol. 2011;26:613–9.PubMedCrossRef

Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, et al. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int. 2006;70:423–31.PubMed

Symmers WS. Thrombocytopenic purpura and haemolytic anaemia after influenza vaccination. Br Med J. 1973;2:614.PubMedCrossRef

10.

Claude D, Delorme N, Schooneman F, Laprevote-Heully MC, Lambert H, Larcan A. Hemolytic-uremic syndrome of viral origin successfully treated by plasma exchange. Presse Med. 1984;13:1003–4.PubMed

11.

Asaka M, Ishikawa I, Nakazawa T, Tomosugi N, Yuri T, Suzuki K. Hemolytic uremic syndrome associated with influenza A virus infection in an adult renal allograft recipient: case report and review of the literature. Nephron. 2000;84:258–66.PubMedCrossRef

12.

Watanabe T. Hemolytic uremic syndrome associated with influenza A virus infection. Nephron. 2001;89:359–60.PubMedCrossRef

13.

Klein PJ, Bulla M, Newman RA, Müller P, Uhlenbruck G, Schaefer HE, et al. Thomsen–Friedenreich antigen in haemolytic-uraemic syndrome. Lancet. 1977;2:1024–5.PubMedCrossRef

14.

Dragon-Durey MA, Fremeaux-Bacchi V. Atypical haemolytic uraemic syndrome and mutations in complement regulator genes. Springer Semin Immunopathol. 2005;27:359–74.PubMedCrossRef

15.

Caprioli J, Peng L, Remuzzi G. The hemolytic uremic syndromes. Curr Opin Crit Care. 2005;11:487–92.PubMedCrossRef

16.

Furlan M, Robles R, Galbusera M, Furlan M, Robles R, Galbusera M, et al. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med. 1998;339:1578–84.PubMedCrossRef

17.

Hirt-Minkowski P, Dickenmann M, Schifferli JA. Atypical hemolytic uremic syndrome: update on the complement system and what is new. Nephron Clin Pract. 2010;114:219–35.CrossRef

18.

Köse O, Zimmerhackl LB, Jungraithmayr T, Mache C, Nürnberger J. New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab. Semin Thromb Hemost. 2010;36:669–72.PubMedCrossRef

19.

Taylor CM, Machin S, Wigmore SJ, Goodship TH. Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom. Br J Haematol. 2010;148:37–47.PubMedCrossRef

20.

Mauad T, Ludhmila AH, Giovanna DC, da Silva LF, Schout D, Galas FR, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med. 2010;181:72–9.PubMedCrossRef

21.

Gilbert CR, Vipul K, Baram M. Novel H1N1 influenza A viral infection complicated by alveolar hemorrhage. Respir Care. 2010;55:623–5.PubMed

22.

Yokoyama T, Tsushima K, Ushiki A, Kobayashi N, Urushihata K, Koizumi T, et al. Acute lung injury with alveolar hemorrhage due to a novel swine-origin influenza A (H1N1) virus. Intern Med. 2010;49:427–30.PubMedCrossRef

23.

Hajjar LA, Mauad T, Galas FR, Kumar A, da Silva LF, Dolhnikoff M, et al. Severe novel influenza A (H1N1) infection in cancer patients. Ann Oncol. 2010;21:2333–41.PubMedCrossRef

Title: Pandemic H1N1 influenza A viral infection complicated by atypical hemolytic uremic syndrome and diffuse alveolar hemorrhage
Authors: Harin Rhee
Sang Heon Song
Yong Jae Lee
Hyun Ju Choi
Jin Hee Ahn
Eun Young Seong
Soo Bong Lee
Ihm Soo Kwak
Publication date: 01-12-2011
Publisher: Springer Japan
Published in: Clinical and Experimental Nephrology / Issue 6/2011
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI: https://doi.org/10.1007/s10157-011-0516-z

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Pandemic H1N1 influenza A viral infection complicated by atypical hemolytic uremic syndrome and diffuse alveolar hemorrhage

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2011

Darbepoetin alfa (KRN321) is safe and effective when administered subcutaneously once every 2 or 4 weeks to patients on peritoneal dialysis in Japan

Accelerated recovery from Candida peritonitis of enteric origin by early surgical drainage in a peritoneal dialysis patient

Clinicopathological findings of immunoglobulin G4-related kidney disease

Effect of the antiplatelet agent cilostazol on endovascular inflammatory biochemical parameters and the clinical symptoms of peripheral artery disease and restless legs syndrome in hemodialysis patients

Diseases of the parathyroid gland in chronic kidney disease

Vascular calcification estimated by aortic calcification area index is a significant predictive parameter of cardiovascular mortality in hemodialysis patients

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page